IVF Archives - Amazing Health Advances

New Israeli Tech Doubles IVF Success Rates

The AHA! Team — Fri, 14 Mar 2025 05:03:06 +0000

Zachy Hennessey via Israel21c – The new method accurately identifying high-quality sperm cells without using potentially harmful chemical dyes. A recent Israeli advancement in fertility science may hold the key to combating the ongoing global decline in fertility rates, by nearly doubling the success rate of in vitro fertilization (IVF). The new technology, developed in the lab of Tel Aviv University Prof. Natan T. Shaked, takes advantage of the light-conducting properties of cells, allowing embryologists to visualize and analyze the internal structure of live sperm cells with extreme accuracy. Researchers can now peek into the microscopic world of reproductive cells with unprecedented detail By using advanced imaging techniques that map cellular structures without invasive procedures, researchers can now peek into the microscopic world of reproductive cells with unprecedented detail. This allows for measurements of previously unattainable parameters like cell mass, volume and structural integrity. Until now, embryologists have had to rely on subjective criteria when evaluating the viability of a given sperm sample — the cells’ external appearance or motility. One commonly used method involves the use of chemical dyes, which better enable the inspection of sperm cells but risks damaging the cells in the process. “Currently, about 90 percent of sperm cells that appear suitable to embryologists actually fail to meet internal morphological criteria,” explained Shaked. “Our technology changes that, offering a new tool to significantly improve IVF outcomes.” The result is an increase in IVF success rates from 34% to 65% — nearly twice the amount. In a clinical trial at Barzilai Medical Center in Ashkelon, the technology resulted in 20 pregnancies out of 31 embryo transfers, compared to just 14 pregnancies out of 41 transfers in the control group. The technology is currently being implemented in clinics throughout Israel (in Ashkelon, Kfar Saba, Ramat HaHayal, Afula and Nahariya), as well as internationally in California and Japan. Dozens of couples have enrolled in clinical trials. Shaked describes it as providing “a new and essential tool to identify sperm cells that meet the World Health Organization criteria for IVF labs.” A description of the new method was published in the journals PNAS, Advanced Science, and Fertility and Sterility. No better time to boost births Fertility rates in developed countries have been declining for decades. According to United Nations statistics, the average global total fertility rate has dropped from 4.8 births per woman in 1970 to 2.2 in 2024. This demographic shift threatens to impact economic stability, social structures and the long-term sustainability of many developed nations. “Fertility issues are becoming increasingly critical: one in six couples faces fertility problems, with male-related issues accounting for half of the cases,” explained Dr. Bozhena Saar-Ryss from Barzilai Medical Center. “Over the past few decades, sperm counts in young, healthy men have dropped by approximately 50%. “Additionally, in certain countries like Japan, Korea and Spain, dramatic declines in birth rates are leading to population shrinkage. The causes for this are diverse and include societal trends like career prioritization and delayed marriages, as well as health issues potentially caused by environmental pollutants,” Saar-Rhys added. These statistics highlight the need for innovative reproductive technologies like the one developed at Tel Aviv University. Selecting the best swimmers Backed by Tel Aviv University’s investment fund and technology transfer company Ramot, the technology is being commercialized through QART Medical, a startup that aims to bring this solution to fertility clinics worldwide. Following the initial success of their research, Shaked and his team are currently developing an additional method to detect DNA fragmentation in sperm cells. “Our goal is to provide embryologists with a technology that enables individual sperm selection based on three essential criteria: motility, internal structure and unfragmented DNA,” says Shaked. “This will allow embryologists to select the best sperm cell for fertilization and dramatically improve success rates in this vital procedure.” To read the original article click here.

The post New Israeli Tech Doubles IVF Success Rates appeared first on Amazing Health Advances.

IVF Pregnancies at Greater Risk of Exposure to Medicines That Can Harm the Baby

The AHA! Team — Tue, 04 Feb 2025 06:09:30 +0000

University of South Australia via Newswise – Pregnancies achieved through IVF and ICSI have the highest exposure to medicines that can harm the fetus, raising the chances of birth defects. A new Australian study has revealed a potential reason why some pregnancies achieved through assisted reproductive technology (ART) may result in birth defects in comparison to naturally conceived pregnancies. Researchers found that in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) pregnancies had the highest exposure to teratogenic medicines that potentially can harm the fetus during the first trimester of pregnancy. These are listed as Category D and X medicines by Australia’s Therapeutic Goods Administration (TGA). The risk associated with the use of Category D medicines in pregnancy may be outweighed by the clinical benefit in individual cases such as management of mental health disorders or epilepsy. Category X medicines on the other hand are strongly discouraged during pregnancy due to the high risk of fetal harm. Researchers from the University of South Australia (UniSA), The University of Western Australia (UWA) and The Kids Research Institute Australia analysed more than 57,000 pregnancies in four conception groups over a two-year period. The groups comprised women using ART (2041); those taking medication to induce ovulation (590); untreated sub-fertile women (2063); and naturally fertile pregnancies (52,987). ART pregnancies had the highest exposure to Category D medications taken in the first trimester. The study found that 4.9% of the ART pregnancies were exposed, compared to only 0.6% of naturally conceived pregnancies. In later trimesters, the trend persisted, with 3.4% of ART pregnancies exposed to Category D medications versus 0.6% of naturally conceived pregnancies. Exposure to Category X medications (causing the most harm during pregnancy) was low across all groups and trimesters, at less than 0.5% of pregnancies. “These differences in exposure are primarily linked to medications used as additional treatment following ART to prevent repeat miscarriages or failed implantation, rather than medications to treat underlying chronic conditions,” says UniSA researcher Dr Anna Kemp-Casey, who led the study. “For example, ART pregnancies, during the study period were more often exposed to progestogens like medroxyprogesterone acetate, which may have been used to treat threatened or recurrent miscarriages,” Dr Kemp says. The five most frequently used Category D/X medications across all pregnancies regardless of conception status were paroxetine, lamotrigine, valproic acid, carbamazepine, and nicotine dependence treatments. UWA co-researcher Professor Roger Hart, also a practising IVF clinician and the national medical director of City Fertility, says the higher exposure to Category D and X medicines in ART pregnancies during the first trimester may contribute to the higher rate of birth defects observed in ART babies. “Although ART pregnancies are carefully planned, medications taken during fertility treatments may inadvertently increase exposure to birth defect risks, particularly during critical periods of fetal development,” Prof Hart says. Researchers say the findings demonstrate that the vast majority of IVF babies are healthy, and do not suggest that ART pregnancies are unsafe, but they underscore the importance of personalised medical care for women undergoing ART treatment and close monitoring for women in early pregnancy. Prof Hart says more research is needed to examine Category D and X medicines exposure in pregnancy as well as underlying maternal medical conditions and their contribution to birth defect risk in ART babies. The study has been published in the Australian and New Zealand Journal of Obstetrics and Gynaecology. Notes for editors “Are assisted reproductive technology pregnancies more likely to be exposed to teratogenic medication? A whole-population study” is authored by researchers from the University of South Australia, Telethon Kids Institute, The University of Western Australia and Curtin University. DOI: 10.1111/ajo.13911 According to the latest ANZARD report, in 2022 more than 20,000 children in Australia (17,963) and New Zealand (2095) were born using ART. Since IVF was introduced in 1978, 10 million children have been born using ART. A 2021 study by US researchers analyzing 1.2 million births found an 18% higher risk of birth defects among IVF babies and a 36% overall greater risk for ICSI births (42% increased risk where ICSI was used to treat male factor subfertility and 30% increased risk with ICSI use for non-male factor subfertility). In IVF pregnancies, sperm is added to a dish containing eggs, and fertilisation occurs naturally, compared to ICSI where a single sperm is injected directly into each egg. The latter procedure is normally used to treat male subfertility but is also an option for unexplained infertility. To read the original article click here.

The post IVF Pregnancies at Greater Risk of Exposure to Medicines That Can Harm the Baby appeared first on Amazing Health Advances.

Researchers Link IVF Use to an Increased Risk of Breast Cancer

AHA Publisher — Wed, 27 Oct 2021 07:00:48 +0000

Wendy Miller via NaturalHealth365 – In vitro fertilization (IVF) has become one of the primary methods of assisted reproductive technology for individuals dealing with infertility. The connection between the medications used during the IVF process and breast cancer has been the subject of many studies, with sometimes differing results. Breast cancer is one of the most common cancers in women. Although an increase in the risk of breast cancer has been linked to hormones like estrogen, there seem to be conflicting results from specific studies between IVF and the disease. Conflicting Evidence: Do Fertility Drugs Increase Breast Cancer Risk? Most women who undergo IVF are required to take medications like gonadotropins and Clomiphene citrate that stimulate the female reproductive system to increase ovulation and prepare the body for an egg to be fertilized. The concern is that if these medications are taken for an extended period, will it cause a dramatic increase in the risk of breast cancer for these women. It seems that for every study that says there is an increase, another study says there is not. So where does that leave you? Should you be concerned? Are You Considering IVF? Know Your Cancer Risk Before Getting Started There is enough evidence that suggests the risk of breast cancer in women who have undergone IVF is real. It has been proven that by taking hormone-based medications like birth control, and now IVF medications, there is a distinct possibility that may lead to an increase in breast cancer or other cancers of the reproductive system. The real issue why the studies have such conflicting results may not lie in the use of the hormones so much as it does with the woman’s predisposition to cancer. Every woman carries some degree of risk for cancers of the female reproductive system. Family history and exposure to environmental toxins also play a role. This Sex Hormone Has a Profound Impact on Cancer Development The key to understanding many of these studies goes back to the link that estrogen and other hormones have on a woman’s risk of developing cancer. A woman who took birth control pills for several years may have an increased risk of breast, ovarian, or uterine cancers, much like a woman who took IVF medications for an extended period. For many women who rely on in vitro fertilization for the opportunity to become a mother, the risk takes on a new perspective. While it’s important to look at each study as objectively as possible, many women will put the risk aside if it will allow them to conceive and carry a child. Here Is How to Calculate Your Individual Cancer Risks In general, the use of IVF medications for any length of time has a link to an increase in the risk of breast cancer. But, just how significant is this risk to you? Unfortunately, there is no way to predict who will succumb to the disease. That’s why it is best ALWAYS to weigh the risks and the benefits of undergoing any medical intervention. Studies have shown that IVF medications can increase breast tissue density and make it more likely for breast cancer to develop. However, it does not mean that every woman who uses them will end up with a diagnosis. Bottom line: your lifestyle, diet, level of activity, and day-to-day stress will all have to be factored in as you calculate your risk. You must also include your past medical history as well as that of your family. When looking at the big picture, you may find that you have a higher than average risk of breast cancer once you add in the use of IVF medications. You must remember, however, your results are unique to you and your health. The studies that have been performed about IVF medications and their association to an increase in the risk of breast cancer are speculative at best. With all of the other possible factors associated with the risk of breast cancer, it is hard to say whether or not the use of IVF medications on their own will have such a dramatic impact. Look at the studies yourself and include your risk factors. Then, talk to your doctor and ask for help assessing your degree of predisposition to cancer. Sources for this article include: NIH.gov BreastCancer.org To read the original article click here.

The post Researchers Link IVF Use to an Increased Risk of Breast Cancer appeared first on Amazing Health Advances.